Rochette L - Search Results

1

Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms.

Rochette L, Guenancia C, Gudjoncik A, Hachet O, Zeller M, Cottin Y, Vergely C. Rochette L, et al. Trends Pharmacol Sci. 2015 Jun;36(6):326-48. doi: 10.1016/j.tips.2015.03.005. Epub 2015 Apr 17. Trends Pharmacol Sci. 2015. PMID: 25895646 Review.

2

Paradoxically, iron overload does not potentiate doxorubicin-induced cardiotoxicity in vitro in cardiomyocytes and in vivo in mice.

Guenancia C, Li N, Hachet O, Rigal E, Cottin Y, Dutartre P, Rochette L, Vergely C. Guenancia C, et al. Among authors: rochette l. Toxicol Appl Pharmacol. 2015 Apr 15;284(2):152-62. doi: 10.1016/j.taap.2015.02.015. Epub 2015 Feb 21. Toxicol Appl Pharmacol. 2015. PMID: 25711856

3

Overweight in mice, induced by perinatal programming, exacerbates doxorubicin and trastuzumab cardiotoxicity.

Guenancia C, Hachet O, Aboutabl M, Li N, Rigal E, Cottin Y, Rochette L, Vergely C. Guenancia C, et al. Among authors: rochette l. Cancer Chemother Pharmacol. 2016 Apr;77(4):777-85. doi: 10.1007/s00280-016-2995-9. Epub 2016 Feb 25. Cancer Chemother Pharmacol. 2016. PMID: 26914236

4

Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis.

Guenancia C, Lefebvre A, Cardinale D, Yu AF, Ladoire S, Ghiringhelli F, Zeller M, Rochette L, Cottin Y, Vergely C. Guenancia C, et al. Among authors: rochette l. J Clin Oncol. 2016 Sep 10;34(26):3157-65. doi: 10.1200/JCO.2016.67.4846. Epub 2016 Jul 25. J Clin Oncol. 2016. PMID: 27458291 Free PMC article. Review.

5

Implications of excess weight in the cardiotoxicity of anthracyclines and trastuzumab in breast cancer.

Guenancia C, Ladoire S, Ghiringelli F, Rochette L, Vergely C, Cottin Y. Guenancia C, et al. Among authors: rochette l. Arch Cardiovasc Dis. 2017 Feb;110(2):69-71. doi: 10.1016/j.acvd.2016.12.004. Epub 2017 Feb 16. Arch Cardiovasc Dis. 2017. PMID: 28216265 Free article. No abstract available.

6

Telomere length and cardiovascular disease.

Saliques S, Zeller M, Lorin J, Lorgis L, Teyssier JR, Cottin Y, Rochette L, Vergely C. Saliques S, et al. Among authors: rochette l. Arch Cardiovasc Dis. 2010 Aug-Sep;103(8-9):454-9. doi: 10.1016/j.acvd.2010.08.002. Epub 2010 Oct 25. Arch Cardiovasc Dis. 2010. PMID: 21074124 Free article. Review.

7

Atrial and vascular oxidative stress in patients with heart failure.

Rochette L, Tatou E, Maupoil V, Zeller M, Cottin Y, Jazayeri S, Brenot R, Girard C, David M, Vergely C. Rochette L, et al. Cell Physiol Biochem. 2011;27(5):497-502. doi: 10.1159/000329951. Epub 2011 Jun 15. Cell Physiol Biochem. 2011. PMID: 21691067 Free article.

8

Oxidative stress and myocardial gene alterations associated with Doxorubicin-induced cardiotoxicity in rats persist for 2 months after treatment cessation.

Richard C, Ghibu S, Delemasure-Chalumeau S, Guilland JC, Des Rosiers C, Zeller M, Cottin Y, Rochette L, Vergely C. Richard C, et al. Among authors: rochette l. J Pharmacol Exp Ther. 2011 Dec;339(3):807-14. doi: 10.1124/jpet.111.185892. Epub 2011 Sep 20. J Pharmacol Exp Ther. 2011. PMID: 21934029

9

Carbon monoxide: mechanisms of action and potential clinical implications.

Rochette L, Cottin Y, Zeller M, Vergely C. Rochette L, et al. Pharmacol Ther. 2013 Feb;137(2):133-52. doi: 10.1016/j.pharmthera.2012.09.007. Epub 2012 Sep 29. Pharmacol Ther. 2013. PMID: 23026155 Free article. Review.

10

Direct and indirect antioxidant properties of α-lipoic acid and therapeutic potential.

Rochette L, Ghibu S, Richard C, Zeller M, Cottin Y, Vergely C. Rochette L, et al. Mol Nutr Food Res. 2013 Jan;57(1):114-25. doi: 10.1002/mnfr.201200608. Mol Nutr Food Res. 2013. PMID: 23293044 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

422 results

Search Page